Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation
{{output}}
Hematopoietic stem cell transplantation (HSCT) remains the only curative option for several hematological malignancies. Its use has continued to grow, with an estimated 23,500 transplants performed annually in the United States alone. The acute toxicities that... ...
